Drug Shortage Report for RIVA-DORZOLAMIDE/TIMOLOL
| Report ID | 98092 |
| Drug Identification Number | 02441659 |
| Brand name | RIVA-DORZOLAMIDE/TIMOLOL |
| Common or Proper name | Riva-dorzolamide / Timolol |
| Company Name | LABORATOIRE RIVA INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | TIMOLOL DORZOLAMIDE |
| Strength(s) | 5MG 20MG |
| Dosage form(s) | SOLUTION |
| Route of administration | OPHTHALMIC |
| Packaging size | 10ml |
| ATC code | S01ED |
| ATC description | ANTIGLAUCOMA PREPARATIONS AND MIOTICS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2019-11-11 |
| Actual start date | |
| Estimated end date | 2020-01-15 |
| Actual end date | 2020-01-21 |
| Shortage status | Resolved |
| Updated date | 2020-02-20 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 660 BOUL. INDUSTRIEL BLAINVILLE, QUEBEC CANADA J7C 3V4 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2020-02-20 | French | Compare |
| v5 | 2020-02-20 | English | Compare |
| v4 | 2019-11-12 | English | Compare |
| v3 | 2019-11-06 | French | Compare |
| v2 | 2019-11-06 | English | Compare |
| v1 | 2019-11-06 | English | Compare |
Showing 1 to 6 of 6